Recent Finacing
Recent Raise
Camena Bioscience develops gSynth, an enzyme‑based DNA synthesis platform producing long, complex synthetic genes with improved accuracy and greener, supply‑chain‑oriented workflows for drug discovery and research.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor
See the team members at Camena Bioscience.
